Asence Pharma Profile
Key Indicators
- Authorised Capital ₹ 9.10 Cr
as on 20-06-2024
- Paid Up Capital ₹ 9.10 Cr
as on 20-06-2024
- Company Age 20 Year, 6 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.68 Cr
as on 20-06-2024
- Satisfied Charges ₹ 10.60 Cr
as on 20-06-2024
About Asence Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.10 Cr and a paid-up capital of Rs 9.10 Cr.
The company currently has active open charges totaling ₹25.68 Cr. The company has closed loans amounting to ₹10.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mayurkumar Swadia, Mohal Sarabhai, Umesh Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ2004PTC045141
- Company No.
045141
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 2004
- Date of AGM
18 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Asence Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohal Sarabhai  | Managing Director | 18-May-2005 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mayurkumar Swadia | Director | 09-Nov-2020 | Current |
| Umesh Shah | Director | 29-Jun-2017 | Current |
| Ashokkumar Shah | Director | 02-Jul-2019 | Current |
Financial Performance and Corporate Structure Insights of Asence Pharma.
Asence Pharma Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Asence Pharma?
In 2022, Asence Pharma had a promoter holding of 100.00%. The company had 1 Subsidiary and 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Sarabhai Chemicals (India) Private LimitedActive 20 years 11 monthsMohal Sarabhai is a mutual person
_PRIVATE_LIMITED.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 04 Jan 2024 | ₹1.40 M | Open |
Others Creation Date: 03 Mar 2023 | ₹1.00 Cr | Open |
Bank Of India Creation Date: 02 Jan 2023 | ₹7.00 Cr | Open |
How Many Employees Work at Asence Pharma?
Asence Pharma has a workforce of 60 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asence Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asence Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
